171 related articles for article (PubMed ID: 24768603)
1. Biological effects of leukotriene E4 on eosinophils.
Steinke JW; Negri J; Payne SC; Borish L
Prostaglandins Leukot Essent Fatty Acids; 2014 Sep; 91(3):105-10. PubMed ID: 24768603
[TBL] [Abstract][Full Text] [Related]
2. Effect of TGF-β1 on eosinophils to induce cysteinyl leukotriene E4 production in aspirin-exacerbated respiratory disease.
Choi Y; Sim S; Lee DH; Lee HR; Ban GY; Shin YS; Kim YK; Park HS
PLoS One; 2021; 16(8):e0256237. PubMed ID: 34437574
[TBL] [Abstract][Full Text] [Related]
3. Characterisation of P2Y(12) receptor responsiveness to cysteinyl leukotrienes.
Foster HR; Fuerst E; Lee TH; Cousins DJ; Woszczek G
PLoS One; 2013; 8(3):e58305. PubMed ID: 23472176
[TBL] [Abstract][Full Text] [Related]
4. Leukotriene E4 elicits respiratory epithelial cell mucin release through the G-protein-coupled receptor, GPR99.
Bankova LG; Lai J; Yoshimoto E; Boyce JA; Austen KF; Kanaoka Y; Barrett NA
Proc Natl Acad Sci U S A; 2016 May; 113(22):6242-7. PubMed ID: 27185938
[TBL] [Abstract][Full Text] [Related]
5. Prostaglandin D2 and leukotriene E4 synergize to stimulate diverse TH2 functions and TH2 cell/neutrophil crosstalk.
Xue L; Fergusson J; Salimi M; Panse I; Ussher JE; Hegazy AN; Vinall SL; Jackson DG; Hunter MG; Pettipher R; Ogg G; Klenerman P
J Allergy Clin Immunol; 2015 May; 135(5):1358-66.e1-11. PubMed ID: 25441644
[TBL] [Abstract][Full Text] [Related]
6. Leukotriene E4 induces MUC5AC release from human airway epithelial NCI-H292 cells.
Shirasaki H; Kanaizumi E; Seki N; Himi T
Allergol Int; 2015 Apr; 64(2):169-74. PubMed ID: 25838093
[TBL] [Abstract][Full Text] [Related]
7. Leukotriene E4-induced pulmonary inflammation is mediated by the P2Y12 receptor.
Paruchuri S; Tashimo H; Feng C; Maekawa A; Xing W; Jiang Y; Kanaoka Y; Conley P; Boyce JA
J Exp Med; 2009 Oct; 206(11):2543-55. PubMed ID: 19822647
[TBL] [Abstract][Full Text] [Related]
8. Differences in urinary leukotriene E4 levels and distribution of eosinophils between chronic rhinosinusitis patients with aspirin-intolerant and -tolerant asthma.
Yamaguchi T; Ishii T; Yamamoto K; Higashi N; Taniguchi M; Okamoto M
Auris Nasus Larynx; 2016 Jun; 43(3):304-8. PubMed ID: 26527517
[TBL] [Abstract][Full Text] [Related]
9. Leukotriene E4 is a full functional agonist for human cysteinyl leukotriene type 1 receptor-dependent gene expression.
Foster HR; Fuerst E; Branchett W; Lee TH; Cousins DJ; Woszczek G
Sci Rep; 2016 Feb; 6():20461. PubMed ID: 26830450
[TBL] [Abstract][Full Text] [Related]
10. Identification of GPR99 protein as a potential third cysteinyl leukotriene receptor with a preference for leukotriene E4 ligand.
Kanaoka Y; Maekawa A; Austen KF
J Biol Chem; 2013 Apr; 288(16):10967-72. PubMed ID: 23504326
[TBL] [Abstract][Full Text] [Related]
11. Prominent role of IFN-γ in patients with aspirin-exacerbated respiratory disease.
Steinke JW; Liu L; Huyett P; Negri J; Payne SC; Borish L
J Allergy Clin Immunol; 2013 Oct; 132(4):856-65.e1-3. PubMed ID: 23806637
[TBL] [Abstract][Full Text] [Related]
12. Cysteinyl leukotrienes induce IL-4 release from cord blood-derived human eosinophils.
Bandeira-Melo C; Hall JC; Penrose JF; Weller PF
J Allergy Clin Immunol; 2002 Jun; 109(6):975-9. PubMed ID: 12063527
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of human eosinophil activation by a cysteinyl leukotriene receptor antagonist (pranlukast; ONO-1078).
Suzuki M; Kato M; Kimura H; Fujiu T; Morikawa A
J Asthma; 2003 Jun; 40(4):395-404. PubMed ID: 12870835
[TBL] [Abstract][Full Text] [Related]
14. Leukotriene E
Lazarinis N; Bood J; Gomez C; Kolmert J; Lantz AS; Gyllfors P; Davis A; Wheelock CE; Dahlén SE; Dahlén B
J Allergy Clin Immunol; 2018 Oct; 142(4):1080-1089. PubMed ID: 29518425
[TBL] [Abstract][Full Text] [Related]
15. Surfactant protein D alleviates eosinophil-mediated airway inflammation and remodeling in patients with aspirin-exacerbated respiratory disease.
Choi Y; Lee DH; Trinh HKT; Ban GY; Park HK; Shin YS; Kim SH; Park HS
Allergy; 2019 Jan; 74(1):78-88. PubMed ID: 29663427
[TBL] [Abstract][Full Text] [Related]
16. Cysteinyl leukotrienes induce human eosinophil locomotion and adhesion molecule expression via a CysLT1 receptor-mediated mechanism.
Fregonese L; Silvestri M; Sabatini F; Rossi GA
Clin Exp Allergy; 2002 May; 32(5):745-50. PubMed ID: 11994100
[TBL] [Abstract][Full Text] [Related]
17. Cysteinyl leukotrienes acting via granule membrane-expressed receptors elicit secretion from within cell-free human eosinophil granules.
Neves JS; Radke AL; Weller PF
J Allergy Clin Immunol; 2010 Feb; 125(2):477-82. PubMed ID: 20159258
[TBL] [Abstract][Full Text] [Related]
18. P2Y12 antagonist attenuates eosinophilic inflammation and airway hyperresponsiveness in a mouse model of asthma.
Suh DH; Trinh HK; Liu JN; Pham le D; Park SM; Park HS; Shin YS
J Cell Mol Med; 2016 Feb; 20(2):333-41. PubMed ID: 26612496
[TBL] [Abstract][Full Text] [Related]
19. Certain subphenotypes of aspirin-exacerbated respiratory disease distinguished by latent class analysis.
Bochenek G; Kuschill-Dziurda J; Szafraniec K; Plutecka H; Szczeklik A; Nizankowska-Mogilnicka E
J Allergy Clin Immunol; 2014 Jan; 133(1):98-103.e1-6. PubMed ID: 23993879
[TBL] [Abstract][Full Text] [Related]
20. Effect of beta2-adrenergic agonists on eosinophil adhesion, superoxide anion generation, and degranulation.
Noguchi T; Nakagome K; Kobayashi T; Ueda Y; Soma T; Nakamoto H; Nagata M
Allergol Int; 2015 Sep; 64 Suppl():S46-53. PubMed ID: 26344080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
